Texas scientists roll out patent-free COVID-19 vaccine, protein-based corbevax has no MRNA

People wearing face masks to curb the spread of COVID-19 walk in downtown Lisbon, Monday, Nov. 29, 2021. Portuguese health authorities on Monday identified 13 cases of omicron, the new coronavirus variant spreading fast globally, among members of the Lisbon-based Belenenses SAD soccer club, and were investigating possible local transmission of the virus outside of southern Africa. (AP Photo/Ana Brigida)

People wearing face masks to curb the spread of COVID-19 walk in downtown Lisbon, Monday, Nov. 29, 2021. (AP Photo/Ana Brigida)

OAN Newsroom
UPDATED 10:26 AM PT – Wednesday, January 5, 2022

Texas scientists rolled out a new COVID-19 vaccine, saying it’s patent-free and can be produced by any manufacturer in any country. The vaccine, called Corbevax, was developed by the Texas Children’s Hospital and Baylor College of Medicine.

It has successfully passed human trials as safe and effective. The new treatment is based off protein-based technology that has been used in other vaccines for decades and it does not use MRNA.

India has already authorized production of 100 million doses per month of the new vaccine. Meanwhile, Texas scientists say not-for-profit vaccines will help defeat COVID-19 quicker.

“We, about 10 years ago, started making coronavirus vaccines and the irony is that all of our processes are used with that in mind,” explained Professor Peter Hotez, M.D. Baylor College of Medicine. “We build in low cost processes from the beginning because our health economist that we’ve collaborated with have always said if you don’t make it for under a few dollars a dose, you might as well not make it at all. So that’s all we know how to do, is make low cost vaccines.” 

The Corbevax vaccine was found to be at least 80 percent efficient against the Delta strain and it’s said to be as effective as other vaccines against Omicron.

MORE NEWS: Hong Kong Leader Dismisses Press Freedom Criticisms

Source link

Amber Coakley
Author: Amber Coakley

Be the first to comment

Leave a Reply

Your email address will not be published.